Physician profile

Joseph Crawford

Urology · Vero Beach, FL

NPI 1689661738

$6,725.20

in general payments reported to CMS, 2019-2025

44 companies · $688 in 2025

The $688 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).

See the full distribution for Urology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,709.50
Travel and Lodging$1,417.03

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Coloplast Corp $1,721.80 2019-2025 Titan, Speedicath
Teleflex LLC $1,084.11 2022-2024 Urolift
Astellas Pharma US INC $944.03 2019-2025 Xtandi, Myrbetriq
Procept Biorobotics Corporation $430.44 2023-2025 Aquabeam Robotic System, Aquabeam System
Axonics, INC. $281.47 2020-2024 Axonics
Janssen Biotech, INC. $223.17 2019-2025 Erleada
Endo Pharmaceuticals INC. $188.66 2019-2024 Xiaflex, Aveed, Edex
Boston Scientific Corporation $149.05 2019-2023 Spaceoar Vue System - 10ml, Greenlight Xps, Rezum Generator
Laborie Medical Technologies Corp. $137.14 2022-2024 Optilume Bph Drug Coated Balloon Catheter
Becton, Dickinson and Company $134.36 2024 Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire
Dendreon Pharmaceuticals LLC $131.14 2021-2025 Provenge
Bayer Healthcare Pharmaceuticals INC. $115.57 2020-2025
Abbvie INC. $105.40 2020-2023 Botox
Urogen Pharma, INC. $100.72 2022-2024 Jelmyto
Valencia Technologies Corporation $91.50 2023-2025 Ecoin Device Kit
Show all 44 companies
CompanyGeneral paymentsYearsTop products
Medtronic, INC. $82.78 2024-2025 Interstim
Pfizer INC. $63.51 2021-2025
Blue Earth Diagnostics $61.52 2021-2024
Olympus America INC. $56.81 2022-2025 Itind System
C. R. Bard, INC. & Subsidiaries $53.55 2020-2021
Rochester Medical Corporation $46.55 2019-2022
Convatec INC. $46.54 2020-2023
Tolmar Pharmaceuticals, INC. $46.16 2019-2022
Alnylam Pharmaceuticals INC. $40.52 2021
Edap Technomed INC $36.58 2025
Endo USA, INC. $33.36 2024-2025 Xiaflex, Aveed, Edex
Ferring Pharmaceuticals INC. $31.47 2025 Adstiladrin
Dentsply Ih INC. $24.26 2021
Astrazeneca Pharmaceuticals LP $23.04 2021
Myovant Sciences INC. $22.88 2022
Immunitybio, INC. $20.11 2025
Philips North America LLC $18.83 2025 Oncology Solution
Foundation Medicine, INC. $17.96 2020
Tolmar, INC. $17.56 2023
Karl Storz Endoscopy-America $17.21 2019
Verity Pharmaceuticals INC. $17.15 2023 Trelstar
Rigicon,INC. $16.44 2022
Therapeuticsmd, INC. $15.06 2019
Cook Medical LLC $14.88 2025 Cook
Antares Pharma, INC. $14.41 2021
Accord Healthcare, INC. $13.97 2022
Novartis Pharmaceuticals Corporation $11.74 2022
Medline Industries LP $11.54 2019
Clarus Therapeutics INC. $10.25 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Joseph Crawford

$6,725.20

in general payments reported 2019-2025

Years
2019-2025
Top company
Coloplast Corp
Context
The $688 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/302747/joseph-crawford

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.